(Vietnamnet) March 7, 2025, Ho Chi Minh City | STADA Pymepharco – a leading pharmaceutical manufacturer and the sole wholly affiliate member of STADA Group (Germany) in Vietnam, has officially entered into a comprehensive strategic partnership with Trung Son Pharma – one of the country’s leading pharmacy chains.
The signing ceremony took place at STADA Pymepharco’s representative office in Ho Chi Minh City, marking an important milestone for both companies as they aim to enhance nationwide access to essential medicines.
The partnership between STADA Pymepharco and Trung Son Pharma is designed to improve the availability of essential healthcare products through Trung Son’s extensive retail network. It will begin with the expansion of STADA Group’s and STADA Pymepharco’s healthcare portfolio at Trung Son, including vitamins, minerals, dietary supplements (VMS), and functional foods (FS).
With STADA Pymepharco operating two EU-GMP-certified pharmaceutical manufacturing plants in Tuy Hoa, Phu Yen, and Trung Son’s extensive pharmacy network across Vietnam, the collaboration is expected to significantly improve access to high-quality healthcare solutions for local consumers and contribute to the enhancement of Vietnam’s overall healthcare ecosystem.
Beyond medicine supply, the two companies will also collaborate on pharmacist training initiatives to strengthen outpatient consultation and treatment quality. Additionally, patient and community health education programs will be prioritized to help raise public awareness of proactive healthcare and effective treatment.
Speaking at the signing ceremony, Mr. Philippe Gautron, General Manager of STADA Pymepharco, emphasized: “This strategic partnership with Trung Son marks a significant step forward and reaffirms our commitment to delivering high-quality healthcare products to the people of Vietnam. By combining STADA Pymepharco’s pharmaceutical manufacturing expertise, global standards, and deep understanding of the local market with Trung Son’s strong retail presence, we believe this collaboration will positively impact public health across Vietnam, ensuring our advanced healthcare solutions reach more people. I believe this partnership not only aligns with STADA Group’s strategic vision of leading in growth and profitability, but also sets new standards in pharmaceutical accessibility and quality in Vietnam”.
Mr. Roh Woong Ho, CEO of Trung Son Pharma, emphasized: “We are delighted to partner with STADA Pymepharco – a company known for its strong global commitment to community health. This collaboration supports Trung Son’s mission to bring the best pharmaceutical products and services to our customers, ensuring that every Vietnamese family can access safe, high-quality international medicines. This partnership not only allows us to expand our product offerings but also presents an opportunity to drive innovation, improve operational efficiency, and adopt international standards in pharmaceutical retail. It enables both companies to further strengthen their positions in Vietnam’s pharmaceutical manufacturing and distribution landscape”.
Both companies expressed confidence that this strategic alliance not only embodies their shared long-term vision but also sets the stage for future innovation in Vietnam’s pharmaceutical sector – standing as a strong testament to their shared commitment to enhancing healthcare quality and accessibility across the country.
By Bich Dao
Source: Vietnamnet
